Echinatine N-oxideCAS# 20267-93-0 |
2D Structure
- Indicine N-oxide
Catalog No.:BCN1996
CAS No.:41708-76-3
- Intermedine N-oxide
Catalog No.:BCN8931
CAS No.:95462-14-9
- Lycopsamine N-oxide
Catalog No.:BCN8951
CAS No.:95462-15-0
- Rinderine N-oxide
Catalog No.:BCN0364
CAS No.:137821-16-0
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
Cas No. | 20267-93-0 | SDF | Download SDF |
PubChem ID | 38946 | Appearance | White to off-white solid |
Formula | C15H25NO6 | M.Wt | 315.36 |
Type of Compound | Nitrogen-containing Compounds | Storage | Desiccate at -20°C |
Solubility | Soluble in methanol and water | ||
Chemical Name | (7-hydroxy-4-oxido-5,6,7,8-tetrahydro-3H-pyrrolizin-4-ium-1-yl)methyl 2-hydroxy-2-(1-hydroxyethyl)-3-methylbutanoate | ||
SMILES | CC(C)C(C(C)O)(C(=O)OCC1=CC[N+]2(C1C(CC2)O)[O-])O | ||
Standard InChIKey | DNAWGBOKUFFVMB-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C15H25NO6/c1-9(2)15(20,10(3)17)14(19)22-8-11-4-6-16(21)7-5-12(18)13(11)16/h4,9-10,12-13,17-18,20H,5-8H2,1-3H3 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Echinatine N-oxide Dilution Calculator
Echinatine N-oxide Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 3.171 mL | 15.8549 mL | 31.7098 mL | 63.4196 mL | 79.2745 mL |
5 mM | 0.6342 mL | 3.171 mL | 6.342 mL | 12.6839 mL | 15.8549 mL |
10 mM | 0.3171 mL | 1.5855 mL | 3.171 mL | 6.342 mL | 7.9274 mL |
50 mM | 0.0634 mL | 0.3171 mL | 0.6342 mL | 1.2684 mL | 1.5855 mL |
100 mM | 0.0317 mL | 0.1585 mL | 0.3171 mL | 0.6342 mL | 0.7927 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Diosmetin 7-glucuronide
Catalog No.:BCN0317
CAS No.:35110-20-4
- 2',6'-Dihydroxy 4',4-dimethoxychalcone
Catalog No.:BCN0316
CAS No.:94441-99-3
- Dihydroavenanthramide D
Catalog No.:BCN0315
CAS No.:697235-49-7
- 23-epi-26-Deoxyactein
Catalog No.:BCN0314
CAS No.:501938-01-8
- 5,6-Dehydro 7,8-dihydrokavain
Catalog No.:BCN0313
CAS No.:3155-51-9
- Cycloartenol
Catalog No.:BCN0312
CAS No.:469-38-5
- trans-Coutaric acid
Catalog No.:BCN0311
CAS No.:27174-07-8
- trans-p-Coumaric acid
Catalog No.:BCN0310
CAS No.:501-98-4
- Convolidine
Catalog No.:BCN0309
CAS No.:63911-32-0
- (-)-Catechin
Catalog No.:BCN0308
CAS No.:18829-70-4
- Castalagin
Catalog No.:BCN0307
CAS No.:24312-00-3
- Cannflavin A
Catalog No.:BCN0306
CAS No.:76735-57-4
- (+/-)-Eriodictyol
Catalog No.:BCN0319
CAS No.:4049-38-1
- Ethyl trans-caffeate
Catalog No.:BCN0320
CAS No.:66648-50-8
- Euphorbol
Catalog No.:BCN0321
CAS No.:566-14-3
- trans-Ferulic acid
Catalog No.:BCN0322
CAS No.:537-98-4
- Fukinolic acid
Catalog No.:BCN0323
CAS No.:50982-40-6
- Grindelic acid
Catalog No.:BCN0324
CAS No.:1438-57-9
- (Rac)-Hesperetin
Catalog No.:BCN0325
CAS No.:69097-99-0
- 3'-Hydroxyflavone
Catalog No.:BCN0326
CAS No.:70460-18-3
- Hyperforin (stable Dicyclohexylammonium salt)
Catalog No.:BCN0327
CAS No.:238074-03-8
- Isomenthone
Catalog No.:BCN0328
CAS No.:491-07-6
- Isoxanthohumol
Catalog No.:BCN0329
CAS No.:521-48-2
- Lactucin
Catalog No.:BCN0330
CAS No.:1891-29-8
Rindera graeca (Boraginaceae) Phytochemical Profile and Biological Activities.[Pubmed:32784926]
Molecules. 2020 Aug 9;25(16). pii: molecules25163625.
Rindera graeca is a Greek endemic plant of the Boraginaceae family which has never been studied before. Consequently, this study attempted to phytochemically examine the aerial parts of this species. Nine phenolic secondary metabolites were identified, consisting of seven caffeic acid derivatives and two flavonol glucosides, namely rutin and quercetin-3-rutinoside-7-rhamnoside. These flavonoids, together with rosmarinic acid, were isolated via column chromatography and structurally determined through spectral analysis. Quercetin-3-rutinoside-7-rhamnoside is an unusual triglycoside, which is identified for the first time in Rindera genus and among Boraginaceae plants. This metabolite was further examined with thermal analysis and its 3D structure was simulated, revealing some intriguing information on its interaction with biological membrane models, which might have potential applications in microcirculation-related conditions. R. graeca was also analyzed for its pyrrolizidine alkaloids content, and it was found to contain echinatine together with Echinatine N-oxide and rinderine N-oxide. Additionally, the total phenolic and flavonoid contents of R. graeca methanol extract were determined, along with free radical inhibition assays. High total phenolic content and almost complete inhibition at experimental doses at the free radical assays indicate a potent antioxidant profile for this plant. Overall, through phytochemical analysis and biological activity assays, insight was gained on an endemic Greek species of the little-studied Rindera genus, while its potential for further applications has been assessed.